Drug Testing Locations - Cheyenne, WY

Drug Testing in Cheyenne, WY

Cheyenne, Wyoming Statistics

In Cheyenne, WY, located in Laramie County, 12% of high school students reported using illicit drugs in the past month.

Laramie County reported an opioid overdose rate of 18 per 100,000 residents in recent years.

In Cheyenne, WY, the incidence of alcohol-related arrests increased by 5% from the previous year.

Methamphetamine-related hospital admissions in Laramie County have seen a significant rise, up by 22%.

Cheyenne, WY noted a 15% increase in drug-related emergency calls over the last recorded year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Cheyenne, WY & Drug Testing Policies

In Cheyenne, WY, employers are increasingly adopting rigorous drug testing policies to ensure workplace safety and productivity. Many companies conduct pre-employment screenings and random drug tests as a deterrent measure against substance misuse.

The Wyoming Workforce Services department provides guidelines to employers about maintaining a drug-free work environment. More information is available on their website.

The implementation of comprehensive drug testing policies in Cheyenne aligns with federal standards, as outlined by the Substance Abuse and Mental Health Services Administration. Visit SAMHSA's website here for more details.

Government Efforts with Drug Problems in Cheyenne, WY

Government efforts to address drug problems in Cheyenne, WY, include collaborative initiatives between local law enforcement and community health services. These programs aim to reduce drug misuse through educational workshops and support groups for addicts and their families.

The Wyoming Department of Health plays a significant role in addressing substance abuse issues statewide. To learn more about their programs and support services, visit the Wyoming Department of Health's website here.

Local Drug Busts & News in Cheyenne, WY

Cheyenne, WY has seen increased efforts in addressing drug-related issues within the community. Law enforcement agencies have been actively involved in operations targeting illegal drug trade. Several collaborative efforts between local police and state authorities have led to significant drug busts, highlighting the community's strong stance against illicit substances.

In recent months, joint operations have successfully dismantled a network distributing methamphetamine in the Cheyenne area. These operations often involve months of undercover work and surveillance. The successful raids have resulted in multiple arrests, aiding in the reduction of illegal drug availability in the region. Such efforts underscore the commitment of authorities to uphold public safety.

Community outreach programs have also gained momentum, aiming to educate residents about the dangers of drug abuse. These initiatives often partner with schools and local organizations to spread awareness. By focusing on prevention and education, Cheyenne aspires to build a resilient community equipped to combat the challenges posed by drug addiction and trafficking.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Cheyenne, WY. Trusted by employers nationwide for accurate results and exceptional service.

Wyoming DOT/Non DOT Physicals

Wyoming Vision Tests

Wyoming Audiograms

Wyoming Respirator Fit Tests

Wyoming Lift Tests

Wyoming Background Checks

Clinical Testing Services

TB Testing in WY

Diabetes Testing in WY

Infectious Disease Testing in WY

Sickle Cell Anemia Testing in WY

Women/Men's Health Testing in WY

Resources & Citations

Wyoming Department of Health - Behavioral Health

Wyoming Prevention Depot

Lifehouse

Cheyenne Health and Wellness Center

Northern Arapaho Department of Family Services

Wellspring Counseling Center

Wyoming Recovery

Mirror Inc.

Drug Testing Near Cheyenne, WY

Tie Siding, WY

Farthing, WY

Egbert, WY

Horse Creek, WY

Buford, WY

Carpenter, WY

Hillsdale, WY

Ranchettes, WY

Orchard Valley, WY

South Greeley, WY

Fox Farm-College, WY

Warren AFB, WY

Laramie, WY

Frequently Asked Questions

Customer Reviews